Hedgehog Pathway Inhibitors Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: HE55F25D174CEN
Market Monitor Global

Abstracts

Hedgehog pathway inhibitors are small molecules that inhibit the activity of a component of the Hedgehog signaling pathway.

This report contains market size and forecasts of Hedgehog Pathway Inhibitors in Global, including the following market information:

Global Hedgehog Pathway Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hedgehog Pathway Inhibitors market was valued at 543 million in 2021 and is projected to reach US$ 1119.5 million by 2028, at a CAGR of 10.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vismodegib Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hedgehog Pathway Inhibitors include Pfizer, Novartis, Roche, Mayne Pharma Group, PellePharm and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hedgehog Pathway Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hedgehog Pathway Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hedgehog Pathway Inhibitors Market Segment Percentages, by Type, 2021 (%)

• Vismodegib
• Erismodegib
• Other

Global Hedgehog Pathway Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hedgehog Pathway Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Basal Cell Carcinoma (BCC)
• Acute Lymphoblastic Leukemia (AML)
• Other

Global Hedgehog Pathway Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hedgehog Pathway Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hedgehog Pathway Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hedgehog Pathway Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis
• Roche
• Mayne Pharma Group
• PellePharm
• Sun Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hedgehog Pathway Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hedgehog Pathway Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEDGEHOG PATHWAY INHIBITORS OVERALL MARKET SIZE

2.1 Global Hedgehog Pathway Inhibitors Market Size: 2021 VS 2028
2.2 Global Hedgehog Pathway Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hedgehog Pathway Inhibitors Players in Global Market
3.2 Top Global Hedgehog Pathway Inhibitors Companies Ranked by Revenue
3.3 Global Hedgehog Pathway Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Hedgehog Pathway Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hedgehog Pathway Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hedgehog Pathway Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 Hedgehog Pathway Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hedgehog Pathway Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hedgehog Pathway Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 Vismodegib
  4.1.3 Erismodegib
  4.1.4 Other
4.2 By Type - Global Hedgehog Pathway Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Hedgehog Pathway Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global Hedgehog Pathway Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hedgehog Pathway Inhibitors Market Size, 2021 & 2028
  5.1.2 Basal Cell Carcinoma (BCC)
  5.1.3 Acute Lymphoblastic Leukemia (AML)
  5.1.4 Other
5.2 By Application - Global Hedgehog Pathway Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Hedgehog Pathway Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global Hedgehog Pathway Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hedgehog Pathway Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Hedgehog Pathway Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Hedgehog Pathway Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global Hedgehog Pathway Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hedgehog Pathway Inhibitors Revenue, 2017-2028
  6.3.2 US Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.3.3 Canada Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.3.4 Mexico Hedgehog Pathway Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hedgehog Pathway Inhibitors Revenue, 2017-2028
  6.4.2 Germany Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.3 France Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.4 U.K. Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.5 Italy Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.6 Russia Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.4.8 Benelux Hedgehog Pathway Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hedgehog Pathway Inhibitors Revenue, 2017-2028
  6.5.2 China Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.5.3 Japan Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.5.4 South Korea Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.5.6 India Hedgehog Pathway Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hedgehog Pathway Inhibitors Revenue, 2017-2028
  6.6.2 Brazil Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.6.3 Argentina Hedgehog Pathway Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hedgehog Pathway Inhibitors Revenue, 2017-2028
  6.7.2 Turkey Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.7.3 Israel Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia Hedgehog Pathway Inhibitors Market Size, 2017-2028
  6.7.5 UAE Hedgehog Pathway Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Hedgehog Pathway Inhibitors Major Product Offerings
  7.1.4 Pfizer Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Hedgehog Pathway Inhibitors Major Product Offerings
  7.2.4 Novartis Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Hedgehog Pathway Inhibitors Major Product Offerings
  7.3.4 Roche Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Mayne Pharma Group
  7.4.1 Mayne Pharma Group Corporate Summary
  7.4.2 Mayne Pharma Group Business Overview
  7.4.3 Mayne Pharma Group Hedgehog Pathway Inhibitors Major Product Offerings
  7.4.4 Mayne Pharma Group Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.4.5 Mayne Pharma Group Key News
7.5 PellePharm
  7.5.1 PellePharm Corporate Summary
  7.5.2 PellePharm Business Overview
  7.5.3 PellePharm Hedgehog Pathway Inhibitors Major Product Offerings
  7.5.4 PellePharm Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.5.5 PellePharm Key News
7.6 Sun Pharmaceutical
  7.6.1 Sun Pharmaceutical Corporate Summary
  7.6.2 Sun Pharmaceutical Business Overview
  7.6.3 Sun Pharmaceutical Hedgehog Pathway Inhibitors Major Product Offerings
  7.6.4 Sun Pharmaceutical Hedgehog Pathway Inhibitors Revenue in Global Market (2017-2022)
  7.6.5 Sun Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hedgehog Pathway Inhibitors Market Opportunities & Trends in Global Market
Table 2. Hedgehog Pathway Inhibitors Market Drivers in Global Market
Table 3. Hedgehog Pathway Inhibitors Market Restraints in Global Market
Table 4. Key Players of Hedgehog Pathway Inhibitors in Global Market
Table 5. Top Hedgehog Pathway Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hedgehog Pathway Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hedgehog Pathway Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hedgehog Pathway Inhibitors Product Type
Table 9. List of Global Tier 1 Hedgehog Pathway Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hedgehog Pathway Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hedgehog Pathway Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hedgehog Pathway Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hedgehog Pathway Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hedgehog Pathway Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hedgehog Pathway Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hedgehog Pathway Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Hedgehog Pathway Inhibitors Product Offerings
Table 32. Pfizer Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Hedgehog Pathway Inhibitors Product Offerings
Table 35. Novartis Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Hedgehog Pathway Inhibitors Product Offerings
Table 38. Roche Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)
Table 39. Mayne Pharma Group Corporate Summary
Table 40. Mayne Pharma Group Hedgehog Pathway Inhibitors Product Offerings
Table 41. Mayne Pharma Group Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)
Table 42. PellePharm Corporate Summary
Table 43. PellePharm Hedgehog Pathway Inhibitors Product Offerings
Table 44. PellePharm Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)
Table 45. Sun Pharmaceutical Corporate Summary
Table 46. Sun Pharmaceutical Hedgehog Pathway Inhibitors Product Offerings
Table 47. Sun Pharmaceutical Hedgehog Pathway Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hedgehog Pathway Inhibitors Segment by Type in 2021
Figure 2. Hedgehog Pathway Inhibitors Segment by Application in 2021
Figure 3. Global Hedgehog Pathway Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hedgehog Pathway Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hedgehog Pathway Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hedgehog Pathway Inhibitors Revenue in 2021
Figure 8. By Type - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 12. US Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 24. China Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hedgehog Pathway Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hedgehog Pathway Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mayne Pharma Group Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PellePharm Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sun Pharmaceutical Hedgehog Pathway Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)